Coeptis Therapeutics pursuing possible acquisition of cell therapy platform By: Pittsburgh Business Times via Business Journals March 29, 2023 at 14:06 PM EDT Coeptis did not offer a timeline as to when it expects to conclude its due diligence analysis, which has since begun. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
